The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / In Advocacy, Slow and Steady Wins the Race

In Advocacy, Slow and Steady Wins the Race

April 1, 2010 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Earlier in the year, it seemed that healthcare reform was stopped in its tracks because of the Massachusetts Senate special election—which placed Republican Scott Brown in the seat held by the “Liberal Lion,” Edward M. Kennedy. The Senate Democrats lost their supermajority and the momentum to pass President Obama’s healthcare reform legislation subsided. But through strong lobbying by the president, Speaker Nancy Pelosi (D-Calif.), and Senate Majority Leader Harry Reid (D-Nev.), Congress passed the Patient Protection and Affordable Care Act (H.R. 3590)—comprehensive healthcare reform—on March 21, and the president signed the bill into law on March 23.

You Might Also Like
  • Advocates for Arthritis: My First Time on the Hill
  • What Has RheumPAC Done for You Lately?
  • Call Your Lawmakers the Week of March 15
Explore This Issue
April 2010
Also By This Author
  • Rheumatology Coding Corner Answer: Sacroiliac Injection with Office Visit

A number of factors almost blocked the passage of healthcare reform. During this process we learned that passing legislation—and developing policies that benefit patients, support physicians and health professionals, advance health research, and improve the U.S. healthcare system—is a very difficult task. Filibusters, party politics, closed-door negotiations, congressional rules, parliamentary procedure, and strong political ideologies all affect legislation and health policies moving through Congress.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although creating beneficial health policies is not an easy battle, it is still worth the fight. Thus, the ACR continues to educate lawmakers and urge support of issues directly affecting rheumatology professionals and patients living with arthritis, rheumatic, and musculoskeletal diseases by going to Capitol Hill and speaking to Congress.

Speaking for Rheumatology on Capitol Hill

Over the years, the ACR has made an impact in Washington. ACR and ARHP members have formed solid relationships with congressional members and their staffs. Offices recognize the ACR logo, and staff desktops include the ACR’s leave-behind item—a bone-shaped stress-reliever—a reminder of meeting people who passionately conveyed personal stories. Some of the stories told on Capitol Hill over the years include those of a young girl with juvenile rheumatoid arthritis who cannot participate in recess or walk up the stairs for her fifth-grade class and a 9/11 firefighter with scleroderma. These patients are living proof of the importance of rheumatology and are not easily forgotten.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Each spring, the ACR goes to Capitol Hill for Advocates for Arthritis to educate Congress on hot issues affecting the rheumatology community. This year, the Advocates for Arthritis fly-in was held March 15–16. During the event, more than 120 rheumatologists, rheumatology health professionals, and patient advocates walked the halls of Congress to lobby legislators on important issues affecting the rheumatology community.

Advocates spoke to Congress about a number of issues, including:

  • A permanent repeal to the sustainable growth rate;
  • The negative effects of the elimination of consultation codes;
  • Legislation to ensure access to osteoporosis testing;
  • The creation of a pediatric subspecialty loan repayment program;
  • The Arthritis Prevention, Control, and Cure Act; and
  • A continued increase for arthritis research funding.

Next month, the ACR board of directors will go to Capitol Hill to reiterate the importance of these issues and expand our network of congressional supporters. As leaders of the ACR, board members dedicate time to ensure that members of Congress are reminded of the issues important to the rheumatology community.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Small Steps Toward Big Legislation

In the 110th Congress, the Arthritis Prevention, Control, and Cure Act (H.R. 1283/S. 626)—a priority of the ACR—passed the U.S. House of Representatives. After four years of educating Congress, urging co-sponsorship, and meeting with House and Senate leadership, Representatives Anna Eshoo (D-Calf.) and Chip Pickering (R-Miss.) ushered the bill through the House only for it to be stopped in the Senate due to the congressional calendar—namely, the 2008 elections—and Senate rules.

Pages: 1 2 3 | Single Page

Filed Under: From the College, Legislation & Advocacy, Professional Topics Tagged With: AC&R, Advocacy, Advocates for Arthritis, Advocating With You, Association of Rheumatology Professionals (ARP), Congress, Healthcare Reform, Legislation, PoliticsIssue: April 2010

You Might Also Like:
  • Advocates for Arthritis: My First Time on the Hill
  • What Has RheumPAC Done for You Lately?
  • Call Your Lawmakers the Week of March 15
  • The ACR’s Advocacy Leadership Conference Brings Volunteers to Washington, D.C.

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.